Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Metadata
Title
Migratory activity of human glioma cell lines in vitro assessed by continuous single cell observation
Authors
Tim Demuth
Nikolai J. Hopf
Oliver Kempski
Dieter Sauner
Monika Herr
Alf Giese
Axel Perneczky
Publication date
01-11-2000
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 7/2000
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1011927004307

Other articles of this Issue 7/2000

Clinical & Experimental Metastasis 7/2000 Go to the issue

OriginalPaper

Tumor cells as the origin of elevated serum α1,3fucosyltransferase in association with malignancy

OriginalPaper

Downregulation of urokinase-type plasminogen activator receptor (uPAR) induces caspase-mediated cell death in human glioblastoma cells

OriginalPaper

Correlation between tumour blood flow and fluorouracil distribution in a hypovascular liver metastasis model

OriginalPaper

Regulation of activator protein-1 activity in the mediastinal lymph node metastasis of lung cancer

OriginalPaper

Local cytokine treatment of HPV16-associated tumours results in inhibition of their lung metastases

OriginalPaper

MMP-9 secretion and MMP-2 activation distinguish invasive and metastatic sublines of a mouse mammary carcinoma system showing epithelial-mesenchymal transition traits
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits